47094-27-9

Basic information

• Product Name: Glycine, N-L-leucyl-, phenylmethyl ester
• CAS NO: 47094-27-9
• Molecular Formula: C15H22N2O3
• Molecular Weight: 278.351
• Mol File: 47094-27-9.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: Glycine, N-L-leucyl-, phenylmethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Glycine, N-L-leucyl-, phenylmethyl ester(47094-27-9)
• EPA Substance Registry System: Glycine, N-L-leucyl-, phenylmethyl ester(47094-27-9)

Safety Data

• Hazardous Substances Data: 47094-27-9(Hazardous Substances Data)

Upstream product

• 66450-17-7 Boc-Leu-HONB 
• 1738-76-7 glycine benzyl ester p-toluenesulfonic acid salt 
• 1738-68-7 Gly-OBz 
• 63366-76-7 (toluene-4-sulfonylamino)acetic acid benzyl ester 
• 13139-15-6 N-tert-butoxycarbonyl-L-leucine 
• 3190-70-3 L-leucine N-carboxyanhydride 
• 37783-45-2 Boc-L-Leu-Gly-OBzl 

Downstream Products

• 403852-48-2 Boc-Ile-Leu-Gly-OBn 
• 150854-44-7 H-Ile-Leu-Gly-Phe-Val-Phe-Thr-Leu-OH 
• 403852-49-3 Boc-Ile-Leu-Gly-Phe-Val-Phe-Thr(Bn)-Leu-OBn 
• 403852-50-6 N-[β-D-(glucopyranuronic acid)-3-nitrobenzyloxycarbonyl]-Gly-Ile-Leu-Gly-Phe-Val-Phe-Thr-Leu-OH 
• 403852-44-8 methyl N-[β-D-glucopyranuronate-3-nitrobenzyloxycarbonyl]-Gly-Ile-Leu-Gly-Phe-Val-Phe-Thr-Leu-OH 
• 119439-70-2 C₅₈H₉₅N₁₇O₁₉S 
• 80451-99-6 H-Asp(OPac)-Leu-Gly-OBzl hydrochloride 
• 504431-32-7 Boc-Gly-Leu-Gly-Val-Pro-ONp 
• 504431-29-2 Boc-Gly-Leu-Gly-Val-Pro-OBzl 
• 118700-52-0 Boc-Gly-Leu-Gly-OBzl 
• 119460-04-7 [(S)-2-(2-{(S)-3-tert-Butoxy-2-[(S)-2-((S)-2-tert-butoxycarbonylamino-propionylamino)-4-carbamoyl-butyrylamino]-propionylamino}-acetylamino)-4-methyl-pentanoylamino]-acetic acid benzyl ester 
• 122899-94-9 {(S)-2-[(2S,3S)-2-(Diethoxy-phosphorylamino)-3-methyl-pentanoylamino]-4-methyl-pentanoylamino}-acetic acid benzyl ester 
• 80451-98-5 Boc-Asp(OPac)-Leu-Gly-OBzl 
• 80451-93-0 Boc-Asp(OBzl)-Leu-Gly-OBzl 

Relevant articles and documents

Functionalization of Sulfonamide-Containing Peptides through Late-Stage Palladium-Catalyzed C(sp3)-H Arylation

Bioactive peptides are emerging as promising candidates of clinic therapeutics. Here, we report a method for late-stage functionalization of sulfonamide-containing peptides through Pd-catalyzed C(sp3)-H arylation. In this protocol, the backbone

Hydrophobicity profile of amino acid residues: A differential scanning calorimetry and circular dichroism study of leucine and isoleucine co-polypeptides of the protein-based polymers of elastin

The inverse temperature transition of hydrophobic folding and assembly of a "host-guest" model system based on the elastin derived polypentapeptide, poly(VPGVG), is employed to determine the relative hydrophobicity of amino acid residues of proteins and p

ATRIOPEPTINS. I. SYNTHESIS OF C-TERMINAL FRAGMENTS

Peptides, corresponding to the C-terminal sequence in atriopeptins, have been synthesized using classical methods of peptide synthesis in solution and characterized by various physicochemical methods.The synthetic strategy and methods are discussed.